Neoadjuvant hormone therapy before radical prostatectomy does not improve disease-specific survival Mitchell S. Steiner Clinical Trials Review Pages: 7 - 8
New insights and candidate genes and their implications for care of patients with hereditary prostate cancer Hyung L. KimGary D. Steinberg OriginalPaper Pages: 9 - 14
The role of prostate-specific antigen velocity in prostate cancer early detection Steven R. PotterH. Ballentine Carter OriginalPaper Pages: 15 - 19
Continence-preserving anatomic radical retropubic prostatectomy: The “no-touch” technique Mitchell S. Steiner OriginalPaper Pages: 20 - 27
What does prostate-specific antigen recurrence mean? Charles R. PoundAlan W. Partin OriginalPaper Pages: 28 - 35
Cryosurgery for prostate cancer: New technology and indications Ronald M. BenoitJeffrey K. CohenRalph J. Miller OriginalPaper Pages: 41 - 47
Recent advances in chemotherapy for advanced prostate cancer Karin B. OlsonKenneth J. Pienta OriginalPaper Pages: 48 - 56
The role of free prostate-specific antigen in prostate cancer detection Misop HanSteven R. PotterAlan W. Partin OriginalPaper Pages: 78 - 82